SCHEMBL20127690

SCHEMBL20127690

c1ccc2c(c1)oc1ccc(-c3ccc(-c4c5ccccc5c(-c5cc6c7ccccc7oc6c6c5oc5ccccc56)c5ccccc45)cc3)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.40
PLA2G4A P47712 4/20 0.40
KDM4E B2RXH2 3/20 0.39
MEN1 O00255 2/20 0.39
MAPT P10636 2/20 0.39
HPGD P15428 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALOX5 P09917 1/20 0.37
AHR P35869 2/20 0.36
PLA2G10 O15496 1/20 0.36
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
GAA P10253 2/20 0.35
CASP3 P42574 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17944904 0.95 MAPT (0.41) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL20127697 0.92 PLA2G2A (0.42) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL20127684 0.92 PLA2G2A (0.37) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL10122232 0.92 ALOX5 (0.40) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL10122243 0.89 AHR (0.41) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL23094344 0.88 PLA2G2A (0.36) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL20127424 0.88 ALOX5 (0.43) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL10122257 0.87 GPR84 (0.36) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL22652670 0.87 PLA2G2A (0.36) PLA2G2APLA2G4AKDM4EMEN1MAPT
SCHEMBL10122236 0.86 PLA2G2A (0.40) PLA2G2APLA2G4AKDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 PLA2G2A 2960/4885PLA2G4A 3780/4885KDM4E 4144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.